BeStock  
Stocks › Biotechnology › IMCR

Immunocore IMCR

US equityMarket cap rank #2944Biotechnology
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±3.1%last 9 reports
Closed higher4 of 944% of the time
Best reaction+5.3%
Worst reaction-4.5%

Stock move on the day after each report

+4.3%2022/Q2-1.5%2022/Q4-3.7%2023/Q2-1.8%2023/Q4+2.8%2024/Q2+5.3%2024/Q4-0.5%2025/Q2-4.5%2025/Q4+3.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q26 Aug 2026Pre Market±14.5%+3.63%Within range
2025/Q425 Feb 2026Pre Market±15.0%-4.51%Within range
2025/Q27 Aug 2025Pre Market±9.1%-0.53%Within range
2024/Q426 Feb 2025Pre Market±17.5%+5.34%Within range
2024/Q28 Aug 2024Pre Market±16.3%+2.76%Within range
2023/Q428 Feb 2024Pre Market±9.8%-1.76%Within range
2023/Q210 Aug 2023Pre Market±9.7%-3.67%Within range
2022/Q41 Mar 2023Pre Market±16.8%-1.46%Within range
2022/Q210 Aug 2022Pre Market–+4.27%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$102.22M-1.4% YoY
Operating profit-$13.61M-89.8% YoY
Net profit-$14.22M-7,935.0% YoY
Diluted EPS-$0.28
Free cash flow$17.74M+441.0% YoY
Operating cash flow$20.09M

Revenue, last 8 quarters

$84.1MDec '24$93.9MMar '25$98.0MJun '25$103.7MSep '25$104.5MDec '25$106.7MMar '26$115.9MJun '26$102.2MSep '26

Net profit, last 8 quarters

$-23.8MDec '24$5.0MMar '25$-10.3MJun '25$-177.0KSep '25$-30.1MDec '25$13.0MMar '26$-808.0KJun '26$-14.2MSep '26

Profitability & balance sheet

Gross margin98.9%
Operating margin-6.8%
Net margin-7.5%
Return on equity-7.9%
Return on assets-2.9%
Return on invested capital-4.0%
Current ratio4.62
Liabilities / assets62.8%
Cash & investments$901.30M
Total debt$433.97M
Net cash (debt)$467.33M

Discussion

No comments yet — be the first to weigh in on IMCR.

Sign in to join the discussion.

Scroll to Top